Breaking News
0

Insys Therapeutics Inc (INSY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Insys's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.73 +0.01    +0.13%
16:00:02 - Closed. Currency in USD ( Disclaimer )
After Hours
7.73
0.00
0.00%
16:19:49 - Real-time Data
Type: Equity
Market: United States
ISIN: US45824V2097 
CUSIP: 45824V209
  • Volume: 208,053
  • Bid/Ask: 7.50 / 7.80
  • Day's Range: 7.64 - 7.82
Insys 7.73 +0.01 +0.13%

INSY Overview

 
Information about the Insys Therapeutics Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close7.72
Day's Range7.64 - 7.82
Revenue109.53M
Open7.72
52 wk Range4.1 - 14
EPS - 3.49
Volume208,053
Market Cap551.35M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)1,665,541
P/E RatioN/A
Beta1.59
1-Year Change - 16.7%
Shares Outstanding74,244,874
Next Earnings DateOct 31, 2018
What is your sentiment on Insys?
or
Market is currently closed. Voting is open during market hours.

Insys Therapeutics Inc News


Insys Therapeutics Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Strong Buy Buy Buy Sell
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Doji Star Bearish 30 1 Aug 17, 2018 03:00PM
Dragonfly Bearish 30 1 Aug 17, 2018 03:00PM
Falling Three Methods 1W 3 Jul 22, 2018
Stick Sandwich 1H 5 Aug 17, 2018 10:00AM
Doji Star Bearish 1W 8 Jun 17, 2018

Insys Therapeutics Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 7.73 7.50 7.80 208,053 +0.13% USD 16:00:02  
  Berlin 6.720 6.530 6.950 0 -1.32% EUR 11:20:00  
  Stuttgart 6.610 0.000 0.000 0 -0.75% EUR 11:30:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tesla 305.50 326.77 303.59 -29.95 -8.93% 18.82M 16:00:01  
  Facebook 173.80 176.22 172.04 -0.90 -0.52% 24.68M 16:00:01  
  Apple 217.58 217.94 213.17 +4.26 +2.00% 34.81M 16:00:02  
  NVIDIA 244.82 252.97 243.73 -12.62 -4.90% 28.31M 16:00:02  
  Amazon.com 1,882.22 1,888.00 1,855.70 -4.30 -0.23% 4.05M 16:00:01  
  Alibaba 172.76 174.20 168.38 +0.77 +0.45% 24.56M 16:00:00  
  Netflix 316.78 324.37 312.96 -5.66 -1.76% 10.35M 16:00:02  
  Micron 47.11 47.36 45.62 +0.01 +0.02% 34.07M 16:00:02  
  Microsoft 107.58 107.90 106.69 -0.06 -0.06% 17.96M 16:00:02  
  AMD 19.770 19.820 18.730 +0.440 +2.28% 60.13M 16:00:01  

Insys Therapeutics Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

343

Equity Type

ORD

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States. Subsys delivers a liquid fentanyl formulation in approximately 100, 200, 400, 600, 800, 1,200 and 1,600 micrograms (mcg) dosages. The Company's lead dronabinol product candidate is Syndros, which is under review for approval at the Food and Drug Administration. In addition, the Company is evaluating sublingual spray, inhaled and intravenous formulations of dronabinol in preclinical studies.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INSY Comments

Write your thoughts about Insys Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ros Gyallay Pap
Ros Gyallay Pap Jun 08, 2018 1:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Such a swing stock. Up and down 4-10 % each day almost..Great to trade.
Reply
0 0
Rogger Bucheli
Rogger Bucheli Feb 23, 2017 1:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When would be a good time to sell or should I just keep on riding the wave.
Reply
0 0
Martin Robert
Martin Robert Feb 23, 2017 1:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
With marijuana legal in Cali, Colorado, dc, new England, and rumor has it NJ by 2018? Ride the wave my friend
Reply
0 0
Ivan Escobedo
Ivan Escobedo Feb 23, 2017 1:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i got in at 10.67 .
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email